Inhibition of human Vγ9Vδ2 T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of human Vγ9Vδ2 T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer
Authors
Keywords
-
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 68, Issue 20, Pages 3385-3399
Publisher
Springer Nature
Online
2011-02-19
DOI
10.1007/s00018-011-0632-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HLA Class I Molecules Regulate IFN- Production Induced in NK Cells by Target Cells, Viral Products, or Immature Dendritic Cells through the Inhibitory Receptor ILT2/CD85j
- (2014) E. Morel et al. JOURNAL OF IMMUNOLOGY
- Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
- (2010) Laurence Amiot et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The role of HLA-G in immunity and hematopoiesis
- (2010) Edgardo D. Carosella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients
- (2010) E. M. de Kruijf et al. JOURNAL OF IMMUNOLOGY
- Human Vγ9Vδ2 T cells: From signals to functions
- (2010) Steven Nedellec et al. SEMINARS IN IMMUNOLOGY
- Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
- (2009) Yu Abe et al. EXPERIMENTAL HEMATOLOGY
- ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse
- (2009) Benoit Favier et al. FASEB JOURNAL
- Human melanoma cell secreting human leukocyte antigen–G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell
- (2009) Emilie Lesport et al. HUMAN IMMUNOLOGY
- γδ T Cells and the Lymphoid Stress-Surveillance Response
- (2009) Adrian C. Hayday IMMUNITY
- Pitfalls on the roadmap to γδ T cell-based cancer immunotherapies
- (2009) Ludovic Martinet et al. IMMUNOLOGY LETTERS
- IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human V 9V 2 T Cells for Adoptive Immunotherapy
- (2009) A. Thedrez et al. JOURNAL OF IMMUNOLOGY
- Characterization of HLA-G expression in renal cell carcinoma
- (2009) B.-L. Li et al. TISSUE ANTIGENS
- Beyond the increasing complexity of the immunomodulatory HLA-G molecule
- (2008) E. D. Carosella et al. BLOOD
- Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
- (2008) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Bridging innate and adaptive immunity through gd T - dendritic cell crosstalk
- (2008) Emmanuel Scotet Frontiers in Bioscience-Landmark
- Expression and regulation of non-classical HLA-G in renal cell carcinoma
- (2008) K. Dunker et al. TISSUE ANTIGENS
- HLA-G: from biology to clinical benefits
- (2008) Edgardo D. Carosella et al. TRENDS IN IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started